Food and Drug Administration [Learn More in MedlinePlus] Code History FY 2026 - No Change, effective from 10/1/2025 through 9/30/2026 FY 2025 - No Change, effective from 10/1/2024 through 9/30/2025 FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024 FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023 FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022 FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021 FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020 FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019 FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018 FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017 FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
[18] [19] At the higher doses used for weight management, headache rates can exceed 10%
When researchers administered Selank concurrently with phenazepam to human volunteers with anxiety spectrum disorders, the patients experienced all the expected benefits of phenazepamyet the drugs usual adverse effects, like memory loss and sleepiness, were significantly decreased by the addition of Selank [10]
The biggest difference comes down to absorption
